
|
|
Clinical Trial Inquiries Todd Joron, BSc, MBA Tel : +1-978-549-4971 |
Boston, MA, San Antonio, TX (PRWEB) March 20, 2012
Intrinsic Imaging, an ISO 9001:2008 certified and GAMP 5 compliant medical imaging core lab, announces today that its’ expertise has contributed to the U.S. Food and Drug Administration’s (FDA) clearance of a neurointerventional medical device.
During the clinical trial used as basis for FDA clearance of the device, Intrinsic Imaging provided imaging core lab services and its team of board certified neuroradiologists provided the complex interpretation and radiological assessment of the devices primary endpoints.
“Intrinsic Imaging is very proud to have acted as the medical imaging core lab on this clinical trial and that our therapeutic, operational and regulatory expertise has contributed to the FDA's clearance of this very important neurointerventional medical device.” said Todd A. Joron, BSc., MBA, President and Chief Operating Officer, Intrinsic Imaging.
Neurointerventional medical devices are used for the prevention and treatment of various central nervous system (CNS) diseases and disorders including Alzheimer's disease, aneurysms, arteriovenous malformations, brain/CNS tumors, epilepsy, head trauma, hydrocephalus, Parkinson's disease, and stroke.
“Clinical trials involving disorders of the central nervous system often present a number of challenges due to the extensive knowledge base required and due to the complexity of image assessments and interpretations.” said James Dix, MD., Medical Director, Neuroradiology at Intrinsic Imaging. “We are pleased our neuroradiology imaging core lab expertise was able to effectively contribute to the clearance of a very beneficial and effective new treatment for patients.”
Intrinsic Imaging radiologists are deeply involved in the diagnosis and treatment of central nervous system disorders and perform hundreds of thousands of CNS related radiologic reviews annually. Their team of 10 full time board certified neuroradiologists specializes in all brain and spine pathology with broad experience and expertise in MRI, CT, diagnostic and interventional angiographic procedures, as well as PET imaging using novel CNS markers.
About Intrinsic Imaging LLC
Located in Boston, Massachusetts, Dallas, Texas and San Antonio, Texas, Intrinsic Imaging is an ISO 9001:2008 certified and GAMP 5 compliant medical imaging core lab providing clinical image management and radiological review services in support of pharmaceutical, biotechnology, medical device and clinical research organizations that are conducting clinical trials. With its team of more than sixty board-certified diagnostic radiologists, its robust and scalable clinical imaging technologies and its ISO certified and registered quality management system, Intrinsic Imaging is ideally positioned to provide unprecedented imaging core lab services around the world.
Contact
Todd Joron
Intrinsic Imaging LLC
+1-888-492-9319
Todd.Joron@IntrinsicCRO.com
www.IntrinsicCRO.com
04/08/2013 - Intrinsic Imaging Appoints Dr. Reta Rupich as Vice President, Medical Imaging Operations
02/27/2013 - Neurological Imaging: Contrast Enhancement in Clinical Trials
02/26/2013 - Intrinsic Imaging Expands Operations - Opens Medical Imaging Campus in Greater Boston
01/17/2013 - Imaging Analysis and Operative Treatment of Diaphyseal Fractures
09/24/2012 - Intrinsic Imaging Obtains ISO 13485 Medical Device Certification
08/23/2012 - Tissue Iron Deposition : MRI Quantitation in Clinical Trials
08/07/2012 - Intrinsic Imaging Undergoes Extensive FDA Audit - Receives Zero 483 Observations
07/18/2012 - Intrinsic Imaging Awarded International Phase III Clinical Trial for Cystic Fibrosis
07/09/2012 - Echocardiography : Advantages in Clinical Trials
07/05/2012 - Orthopedic Device Assessments : Medical Imaging Challenges in Clinical Trials
07/03/2012 - Traumatic Brain Injury: Medical Imaging in Clinical Trials
06/03/2012 - Advances in Imaging of Rheumatoid Arthritis
04/17/2012 - Metastatic Colorectal Cancer and Locoregional Therapies
03/08/2012 - Quantitative Neuroimaging of Alzheimer’s Disease
03/06/2012 - Intrinsic Imaging Implements ISPE GAMP 5
01/31/2012 - Intrinsic Imaging Awarded Cardiovascular Clinical Trial
01/10/2012 - Intrinsic Imaging Awarded Important Clinical Trial for the Evaluation of Breast Cancer